{"url":"https://newsforagent.com/news/2026-10-23/united-therapeutics-rochester-hangar","markdown_url":"https://newsforagent.com/news/2026-10-23/united-therapeutics-rochester-hangar.md","title":"United Therapeutics to Build $9 Million Rochester Hangar","headline":"United Therapeutics to Build $9 Million Hangar at Rochester International Airport","description":"United Therapeutics will build a $9 million hangar at Rochester International Airport, starting in early 2027 and finishing in 2028 under a 40-year lease.","section":"Expansion","published_at":"2026-10-23T22:12:08+00:00","modified_at":"2026-10-23T22:12:08+00:00","author":"News Desk","key_takeaways":["United Therapeutics will build a 27,000- to 33,000-square-foot hangar at Rochester International Airport for $9 million, with construction starting in early 2027 and completion in 2028.","The company leases a 143,720-square-foot plot from the city of Rochester for 40 years at $0.35 per square foot, or $50,302 per year, with a 3% annual escalation.","United Therapeutics invested $6.9 million earlier in infrastructure improvements, so 75% of annual fees are credited back, leaving the city $12,575.50 in the first year."],"companies":[{"name":"United Therapeutics","is_primary":true,"profile_url":"https://akta.pro/company-profiles/0004f67/united-therapeutics","website":"http://www.unither.com"}],"source":{"publisher":"Yahoo","title":"United Therapeutics to build a $9 million hangar at Rochester's airport","url":"https://www.yahoo.com/news/articles/united-therapeutics-build-9-million-212400527.html"},"other_sources":[],"tags":["Expansion","United Therapeutics"],"body_markdown":"[United Therapeutics](https://akta.pro/company-profiles/0004f67/united-therapeutics) will build a $9 million corporate airplane hangar at Rochester International Airport on land leased from the city of Rochester, with construction starting in early 2027 and completion in 2028. The company said the 27,000- to 33,000-square-foot hangar will sit about six miles from its recently completed Stewartville facility. The details were reported by [Yahoo](https://www.yahoo.com/news/articles/united-therapeutics-build-9-million-212400527.html).\n\n## United Therapeutics' Hangar Plans at Rochester Airport\n\nUnited Therapeutics is a Maryland-based biotech that develops treprostinil-based therapies for pulmonary arterial hypertension and is building an organ manufacturing platform spanning xenotransplantation and bioengineered organs. The $110 million Thomas E. Starzl Xenograft Production Facility in Stewartville's Schumann Business Park will raise gene-edited pigs for kidney and heart transplants in humans. The proximity of the Rochester airport for transporting organs was a major factor in the company's decision to build the facility in southeastern Minnesota.\n\n\"We see Minnesota as an important hub and piece of the puzzle for the future of our company's xenotransplantation program. RST was a logical location for building a hangar,\" stated Thomas Kaufman, United Therapeutics' vice president of corporate real estate, in an announcement released by the airport. Kaufman described the design as a \"beautiful aesthetic\" that will be noteworthy for an airplane hangar.\n\nThe hangar will use a sustainability-focused mass timber structural system to reduce construction carbon by relying less on steel and concrete. Timber will be visible from inside, and the exterior is expected to incorporate wood using a traditional Japanese technique that chars the wood's surface. The building will rise on open land just west of the airport by State Highway 30.\n\n## United Therapeutics' Lease Terms With Rochester\n\nAccording to akta.pro [company records](https://akta.pro/company-data), United Therapeutics is building a $110 million facility in Rochester, Minnesota to produce gene-edited pig organs for transplantation as part of regional health tech ecosystem development. The same records list FY2025 reported revenue of $3.18 billion and Q1 2026 revenue of $781.5 million.\n\nThe 40-year lease, with two options to extend it an additional five years, requires United Therapeutics to pay $0.35 per square foot, or $50,302 per year, with an annual escalation rate of 3%. United Therapeutics invested $6.9 million earlier to pay for infrastructure improvements to prepare the property, so 75% of the annual fees will be credited to UT to recoup that earlier investment. The city will collect $12,575.50 of the $50,302 for the first year.\n\n## Earlier United Therapeutics Coverage\n\nOn September 30, 2026, Liquidia Corp. fell 25% after a court denied its motion to strike in a patent dispute with United Therapeutics over Yutrepia, according to Seeking Alpha. The judge found Liquidia infringed claims 1 and 14 of the '327 patent, and United Therapeutics rose 13%.\n\nOn October 2, 2026, Markets Daily reported that United Therapeutics beats Emergent Biosolutions on 12 of 14 factors, including profitability and valuation. On October 12, 2026, Markets Daily reported that United Therapeutics beats Xenon Pharmaceuticals on 8 of 15 factors, including profitability and revenue.\n\n## What Comes Next for the Hangar\n\nConstruction is estimated to take 12 months and be completed in 2028. The development plans show areas next to the UT hangar marked as \"Future Hangar(s)\" and \"Future Ramp.\"\n","publisher":{"name":"News for Agent","url":"https://newsforagent.com"}}